Medical System Network Co., Ltd. (4350.T)
JPY 415.0
(-0.72%)
JPY 415.0
(-0.72%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 6.99 Billion JPY | 6.21% |
| 2022 | 6.12 Billion JPY | -10.37% |
| 2021 | 6.7 Billion JPY | 9.9% |
| 2020 | 6.42 Billion JPY | 38.65% |
| 2019 | 4.64 Billion JPY | 7.01% |
| 2018 | 4.2 Billion JPY | -25.0% |
| 2017 | 5.71 Billion JPY | 21.86% |
| 2016 | 4.71 Billion JPY | -23.17% |
| 2015 | 6.06 Billion JPY | 31.14% |
| 2014 | 4.64 Billion JPY | 20.65% |
| 2013 | 3.8 Billion JPY | 15.82% |
| 2012 | 3.49 Billion JPY | 0.0% |
| 2011 | - JPY | -100.0% |
| 2010 | 2.41 Billion JPY | 3.49% |
| 2009 | 2.24 Billion JPY | 30.4% |
| 2008 | 1.81 Billion JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 1.25 Billion JPY | -2.12% |
| 2023 FY | - JPY | 6.21% |
| 2023 Q4 | 1.59 Billion JPY | 12.21% |
| 2023 Q3 | 1.41 Billion JPY | 5.27% |
| 2023 Q2 | 1.34 Billion JPY | 168.66% |
| 2023 Q1 | 501 Million JPY | -45.95% |
| 2022 Q3 | 1.32 Billion JPY | 43.96% |
| 2022 Q4 | 927 Million JPY | -29.93% |
| 2022 Q1 | 461 Million JPY | -47.07% |
| 2022 Q2 | 919 Million JPY | 99.35% |
| 2022 FY | - JPY | -10.37% |
| 2021 Q4 | 871 Million JPY | -32.69% |
| 2021 Q3 | 1.29 Billion JPY | -3.86% |
| 2021 FY | - JPY | 9.9% |
| 2021 Q1 | 983 Million JPY | 29.68% |
| 2021 Q2 | 1.34 Billion JPY | 36.93% |
| 2020 Q2 | 1.51 Billion JPY | 21728.57% |
| 2020 Q3 | 1.42 Billion JPY | -5.75% |
| 2020 Q4 | 758 Million JPY | -46.88% |
| 2020 FY | - JPY | 38.65% |
| 2020 Q1 | -7 Million JPY | -101.72% |
| 2019 Q2 | 522 Million JPY | 35.23% |
| 2019 FY | - JPY | 7.01% |
| 2019 Q4 | 406 Million JPY | -15.59% |
| 2019 Q3 | 481 Million JPY | -7.85% |
| 2019 Q1 | 386 Million JPY | -29.95% |
| 2018 Q4 | 551 Million JPY | -12.82% |
| 2018 Q1 | 251 Million JPY | -74.28% |
| 2018 FY | - JPY | -25.0% |
| 2018 Q2 | 302 Million JPY | 20.32% |
| 2018 Q3 | 632 Million JPY | 109.27% |
| 2017 Q3 | 1.11 Billion JPY | 51.5% |
| 2017 FY | - JPY | 21.86% |
| 2017 Q2 | 734 Million JPY | 14.69% |
| 2017 Q1 | 640 Million JPY | -28.49% |
| 2017 Q4 | 976 Million JPY | -12.23% |
| 2016 Q4 | 895 Million JPY | 15.34% |
| 2016 Q1 | 261 Million JPY | -78.85% |
| 2016 FY | - JPY | -23.17% |
| 2016 Q2 | 396 Million JPY | 51.72% |
| 2016 Q3 | 776 Million JPY | 95.96% |
| 2015 Q3 | 1.01 Billion JPY | 2.53% |
| 2015 FY | - JPY | 31.14% |
| 2015 Q2 | 989 Million JPY | 9.65% |
| 2015 Q4 | 1.23 Billion JPY | 21.7% |
| 2015 Q1 | 902 Million JPY | 0.13% |
| 2014 Q3 | 934.93 Million JPY | 33.68% |
| 2014 Q2 | 699.36 Million JPY | 132.88% |
| 2014 Q1 | 300.31 Million JPY | 187.68% |
| 2014 FY | - JPY | 20.65% |
| 2014 Q4 | 900.81 Million JPY | -3.65% |
| 2013 Q3 | 895.16 Million JPY | 36.38% |
| 2013 Q4 | 104.39 Million JPY | -88.34% |
| 2013 Q1 | 654.17 Million JPY | 9.28% |
| 2013 Q2 | 656.35 Million JPY | 0.33% |
| 2013 FY | - JPY | 15.82% |
| 2012 Q1 | 351.69 Million JPY | 0.0% |
| 2012 Q3 | 790.34 Million JPY | 81.97% |
| 2012 FY | - JPY | 0.0% |
| 2012 Q4 | 598.62 Million JPY | -24.26% |
| 2012 Q2 | 434.32 Million JPY | 23.49% |
| 2011 Q3 | 817.21 Million JPY | 2.27% |
| 2011 Q2 | 799.07 Million JPY | -5.53% |
| 2011 Q1 | 845.81 Million JPY | -0.82% |
| 2011 FY | - JPY | -100.0% |
| 2011 Q4 | - JPY | -100.0% |
| 2010 Q2 | 602.95 Million JPY | 17.35% |
| 2010 Q4 | 852.78 Million JPY | 2.74% |
| 2010 Q3 | 830.01 Million JPY | 37.66% |
| 2010 FY | - JPY | 3.49% |
| 2010 Q1 | 513.78 Million JPY | -14.37% |
| 2009 Q4 | 600.03 Million JPY | -17.51% |
| 2009 FY | - JPY | 30.4% |
| 2009 Q3 | 727.37 Million JPY | 7.72% |
| 2009 Q2 | 675.22 Million JPY | 30.93% |
| 2009 Q1 | 515.71 Million JPY | -3.06% |
| 2008 Q4 | 531.99 Million JPY | -16.72% |
| 2008 FY | - JPY | 0.0% |
| 2008 Q3 | 638.8 Million JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| HEARTSEED INC | -1.44 Billion JPY | 583.06% |
| Cawachi Limited | 11.85 Billion JPY | 40.972% |
| Pharmarise Holdings Corporation | 2.08 Billion JPY | -235.379% |
| Qol Holdings Co., Ltd. | 14.21 Billion JPY | 50.771% |
| MatsukiyoCocokara & Co. | 98.01 Billion JPY | 92.863% |
| Welcia Holdings Co., Ltd. | 67.62 Billion JPY | 89.655% |
| Create SD Holdings Co., Ltd. | 24.34 Billion JPY | 71.267% |
| NIHON CHOUZAI Co.,Ltd. | 14.65 Billion JPY | 52.262% |
| COSMOS Pharmaceutical Corporation | 51.42 Billion JPY | 86.396% |
| Tsuruha Holdings Inc. | 67.2 Billion JPY | 89.59% |
| Ohki Healthcare Holdings Co.,Ltd. | 3.81 Billion JPY | -83.333% |
| Satudora Holdings Co.,Ltd. | 2.71 Billion JPY | -157.965% |
| Kusuri No Aoki Holdings Co., Ltd. | 30.64 Billion JPY | 77.168% |
| Shinnihonseiyaku Co., Ltd. | 4.18 Billion JPY | -67.049% |
| Sugi Holdings Co.,Ltd. | 50.74 Billion JPY | 86.213% |
| YAKUODO HOLDINGS Co., Ltd. | 8.16 Billion JPY | 14.296% |
| Astena Holdings Co., Ltd. | 4.17 Billion JPY | -67.68% |
| Genky DrugStores Co., Ltd. | 14.47 Billion JPY | 51.665% |
| Ain Holdings Inc. | 31.22 Billion JPY | 77.593% |
| Sundrug Co.,Ltd. | 56.23 Billion JPY | 87.56% |